Molecular Dynamics (Israel) Ltd. is a subsidiary of Molecular Dynamics that focuses on the research and development of advanced imaging technologies and clinical applications. The company’s flagship product, Valiance X12, which is based on CZT technology, offers significant improvements in image quality, scan time, and patient dose for whole body functional imaging. These advancements, combined with innovative applications, have the potential to enhance diagnosis, treatment optimization, and monitoring, ultimately leading to more cost-effective treatments and improved clinical outcomes. Founded in 2013 and based in Israel, Molecular Dynamics (Israel) Ltd. operates within the Analytics, Health Care, and Medical Devices industries. As of now, there is no public information available regarding the company's latest investment round or the participating investors. With its pioneering technologies and applications, Molecular Dynamics (Israel) Ltd. stands at the forefront of revolutionizing imaging and clinical practices in the healthcare industry.
There is no investment information
No recent news or press coverage available for Molecular Dynamics (Israel) LTD.